What are the benefits of endoscopic ultrasound in the staging of pancreatic cancer? Female patient, 73 years old, with a history of jaundice, epigastric pain radiating to the back, and weight loss of 15 kg in three months. She was referred to our hospital with a possible diagnosis of cancer in the head of the pancreas, with evidence of increased pancreatic head and dilatation of intra-and extra-hepatic biliary ducts on abdominal computed tomography and magnetic resonance cholangiography. Due to obstructive jaundice, a retrograde cholangiopancreatography was performed, showing partial stenosis of the distal common bile duct with dilatation of bile ducts, which was drained by inserting two biliary plastic stents. An endoscopic ultrasound was requested to further study the pancreas and adjacent structures. During the investigation, a hypoechoic heterogeneous lesion measuring 35 x 30 mm and presenting ill-defined margins was seen in the pancreatic head. There were also signs of vascular involvement, with loss of acoustic interface with the wall of the portal vein and absence of vascular flow (thrombosis). Furthermore, dilatation of the main pancreatic duct (6 mm) in the regions of body and tail of the pancreas upstream to the lesion described above was observed. Echo-guided punctures were performed in the lesion for histological clarification. Pancreatic cancer is associated with poor prognosis. After diagnosis, the survival rate is about 3% at 5 years and only 15% of tumors are resectable. Surgical resection of the tumor is still the only curative treatment and, therefore, an accurate preoperative staging is mandatory to avoid the surgical treatment of unresectable lesions. 1 In the absence of distant metastases, which contraindicate surgery, assessment of vascular invasion is the most important parameter to determine the resectability of the lesion. Invasion is found in 21 to 64% of cases. 2 Endoscopic ultrasound is a test that complements the evaluation made by other imaging studies (CT or MRI), providing an accurate assessment of peripancreatic vasculature and the relationship between the tumor and adjacent structures. Studies have shown that the sensitivity to detect vascular invasion through endoscopic ultrasound ranges from 50 to 100%, with specificity between 58 and 100%. 2 In addition to the image data, it enables the realization of intra-pancreatic and lymph node biopsies 1, 3 that can change the therapeutic approach. Fine needle aspiration (FNA) has a diagnostic accuracy approaching 90%. Obtaining histological material from biopsy plays an important role to initiate palliative or neoadjuvant treatment.
